Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation
The two major aggrecanases involved in osteoarthritis (OA) are ADAMTS-4 and ADAMTS-5. Knock-out studies suggested that ADAMTS-5, but not ADAMTS-4, is the major aggrecanase in murine OA. However, studies of human articular cartilage suggest that ADAMTS-4 also contributes to aggrecan degradation in human OA. This study investigated ADAMTS-4 in human OA. While ADAMTS-4 was virtually absent in control cartilage, numerous ADAMTS-4 immuno-positive chondrocytes were present in OA cartilage and their numbers increased with disease severity. RT-PCR confirmed expression, especially in the surface zone. DNA methylation was lost at specific CpG sites in the ADAMTS-4 promoter in OA chondrocytes, suggesting that the increased gene expression was more than a simple up-regulation, but involved loss of DNA methylation at specific CpG sites, resulting in a heritable and permanent expression of ADAMTS-4 in OA chondrocytes. These results suggest that ADAMTS-4 is epigenetically regulated and plays a role in aggrecan degradation in human OA.
KeywordsADAMTS-4 Osteoarthritis DNA methylation Gene expression Immunocytochemistry Histology
This study was supported by grant no. 43747 from the Wessex Medical Trust. All authors thank the Orthopaedic Surgeons of Southampton General Hospital, especially Mr. Simon Tilley and Mr. Ben Bolland, for supplying the femoral heads following joint replacement surgery. We are grateful to Miss Wai Mun Loo for contributing Fig. 2j and k. We also gratefully acknowledge funding by the Wessex Medical Trust and all the “Great Hip & Knee” Walkers without whom this research would not have been possible. Last, but not least, the excellent editing by Dr. Felix Bronner, University of Connecticut Health Center, is also much appreciated.
- 6.Sandy JD, Verscharen C (2001) Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J 358:615–626. doi:10.1042/0264-6021:3580615 PubMedCrossRefGoogle Scholar
- 10.Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS (1997) Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 100:93–106. doi:10.1172/JCI119526 PubMedCrossRefGoogle Scholar
- 12.Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, Arai M, Blasio-Smith E, Dorner AJ, Georgiadis KE, Jin M, Tan XY, Morris EA, LaVallie ER (2004) ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 23:219–230. doi:10.1016/j.matbio.2004.05.004 PubMedCrossRefGoogle Scholar
- 16.Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, Kokubun S, Bronner F (2005) Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52:3110–3124. doi:10.1002/art.21300 PubMedCrossRefGoogle Scholar
- 19.Roach HI, Hashimoto K (2007) PCR-based methods to determine DNA methylation status at specific CpG sites using methylation-sensitive restriction enzymes. In: Hughes S, Moody A (eds) Methods express: PCR. Scion Publishing Ltd, Oxfordshire, pp 279–292Google Scholar
- 21.Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, Flannery CR, Kanki K, Wang E, Peluso D, Yang Z, Majumdar MK, Morris EA (2004) Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 50:2547–2558. doi:10.1002/art.20558 PubMedCrossRefGoogle Scholar
- 22.Pelletier JP, Boileau C, Boily M, Brunet J, Mineau F, Geng C, Reboul P, Laufer S, Lajeunesse D, Martel-Pelletier J (2005) The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 7:R1091–R1102. doi:10.1186/ar1788 PubMedCrossRefGoogle Scholar